New system forecasts stock price up to 21 days in the future.

Most conversations about Linde end with green hydrogen. That framing misses what disciplined money is actually pricing in as the calendar turns to Q4.

Strip away the energy-transition language and what you find at the core of LIN is a contractual revenue floor that few industrial businesses can match. As of September 30, 2026, Linde carried approximately $66 billion in remaining performance obligations tied to minimum purchase requirements and plant sales. That figure was approximately $62 billion as of December 31, 2025. It does not include any gas sold above contracted minimums, which can be substantial.

The contracts behind that number are not short-cycle agreements. On-site supply arrangements typically run 10 to 20 years, carry take-or-pay minimums, and embed price escalators tied to inflation. When a customer signs one, Linde builds a dedicated air-separation or hydrogen unit on their site. The customer then pays whether they use the gas or not. That is the structural reason LIN behaves differently from other industrials when growth fears rise: the revenue does not wait on the economy to cooperate.

The Q3 results posted October 29 reinforced that picture. Record quarterly sales of $9.4 billion came in 9% above last year, adjusted EPS of $4.59 exceeded consensus by about $0.07, and operating cash flow reached $3.2 billion. Full-year guidance was lifted to $17.82 to $17.92 in adjusted EPS, implying 8% to 9% growth. Capital expenditures of $5.5 billion to $6 billion are going directly into the project backlog, which management said sits close to $8 billion on a sale-of-gas basis headed into year-end.

Electronics is the loudest growth engine right now. CEO Sanjiv Lamba said on the earnings call that roughly $2 billion of backlog projects are already under execution, with staggered startups over the next two to three years. On July 31, Linde announced a $1 billion commitment to expand its Phoenix semiconductor gas complex under a new long-term agreement with one of the world’s largest chip manufacturers, with a parallel Taiwan award through its Linde LienHwa joint venture. That is not green-hydrogen speculation. It is contracted, capital-deployed, infrastructure already being built.

The semiconductor buildout driving Linde’s Phoenix expansion runs through a single manufacturing chokepoint. TSMC is the foundry that actually produces the advanced chips requiring the specialty gases Linde is contracted to supply.

What experienced traders recognize here is a business that behaves like a toll road. Industrial gases is effectively a global oligopoly, and most of Linde’s revenue compounds through fixed escalators regardless of what the broader market does in November or December. The stock is not cheap on any simple multiple, but capital flowing into LIN into year-end is not making a valuation argument. It is buying duration, contract visibility, and an earnings base that does not require a macro tailwind to grow.

The Trader’s Lesson

Defensive capital at year-end does not always mean buying utilities or consumer staples. Sometimes the most defensible position is a business with a $66 billion contractual revenue floor. The question worth asking about any position you hold into December is whether its earnings depend on conditions being favorable, or whether they arrive regardless. Linde’s answer to that question is what makes it worth watching right now.